SAPPORO CLINICAL LABORATORY INC.
札幌臨床検査センター株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 9776
FY2024 · 2025-03-31
| Gross margin | 30.5% |
| Operating margin | 3.5% |
| Net margin | 2.3% |
| Return on equity | 4.2% |
| Return on assets | 2.8% |
| Revenue growth (YoY) | 2.3% |
| EPS (basic) | ¥148.35 |
| EPS growth (YoY) | 30.0% |
| Current ratio | 2.13x |
| Equity ratio | 67.1% |
| Book value / share | ¥3,575.27 |
| Free cash flow | -491 M |